-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BETFRGoIZFJiZVZcYjOVkEz53xwmko5x8BeHuAULUlAMXGTk0ij00QscNLy6qUW+ Qxk2Rc/A9OSJUNjF13H0+Q== 0000000000-07-008031.txt : 20070402 0000000000-07-008031.hdr.sgml : 20070402 20070215093130 ACCESSION NUMBER: 0000000000-07-008031 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070215 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 PUBLIC REFERENCE ACCESSION NUMBER: 0001206774-06-000397 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0Y(#`@;V)J(#P\+TQI;F5AF4@-C`O4')E=B`Y,S')E9@T*,`T*)25%3T8-"B`@(`T*-3D@,"!O8FH\/"],96YG=&@@-SDO0R`X M."]&:6QT97(O1FQA=&5$96-O9&4O22`Q,3`O3"`W,B]3(#,X/CYS=')E86T- M"GC:8F!@8&=@8-[,``1<[0RH@`F(61@X&IB1Q-BAF('!AX%+6>R_9HQFUP&8 M:L$\J"X+(&9D8."S@M#,)G#];`P,RFP048;/``$&`-9C!],-"F5N9'-TF4@-#DO5'EP92]84F5F/CYS=')E86T- M"GC:8F)B9&!B8&`<[!@@P``KS0"!#0IE;F1S=')E86T-96YD;V)J#34P(#`@ M;V)J/#PO36%R:TEN9F\\/"],971T97)S<&%C949L86=S(#`O36%R:V5D('1R M=64^/B]-971A9&%T82`U(#`@4B]0:65C94EN9F\\/"]-87)K96101$8\/"], M87-T36]D:69I960H1#HR,#`W,#(Q-3`Y,CDP,2D^/CX^+U!A9V5S(#0@,"!2 M+U!A9V5,87EO=70O3VYE0V]L=6UN+U-T'1=+T5X=$=3=&%T93P\+T=3,"`U-R`P M(%(^/CX^+U1Y<&4O4&%G93X^#65N9&]B:@TU,B`P(&]B:CP\+U-U8G1Y<&4O M5')U951Y<&4O1F]N=$1ETHT[:JIKV(1O,D`XD*Q-FEO[ZVDX``3:D4O.`8Q*=>WW/\?'- MZ`'>OQ_=3SY.`<.'#^/I!`88G@<$2AB,?GQ4]^O!.!N,L@P#@6RNGF:%>C=[ M4S^0K8%@/?ZC_Y)`J!JQ'E(,,4Y0&D&V&GC@9W\/;K/![;W"'QUBDEW,HQ!' M*%'*$;F,0GN@)`2QRRBL!TH4(WX9)>R!PAF*+Z-P*PI&&.-8US_8W;X=ESQB M:5?R)^^W,H>[O%B7*S_URJ6`O)K!K^@1P7U>+L'_*_MD"QW90^]9/XY'HQTY M!O2QJ;]!A(F2A&-E<8_Z$'J-J^0Z"D^3/5?_T_7G#ZXG=^*KW.1R"X0/@6IF M'(FG/1)/PFOR(+@'3(RO[C[[]C/:(GN9$79&.^?QGG:)8++(Y5*LX1;!>//\ M/(2'!9HB9U3[=C51Z4'<]#QJR#I=/'DJ9"E7?N+EE='U9%&*.=Q^%\6F*5]] M[@GX>3XO_2#V"B&=8B?V36\2"`^YA.>YT+13UY,W+NN)W*X;M>R\S:D0*HLB M7ZZ'\+$JD#N\W2U."-"WI^$)WVF$$C5_R.7+6[Z%+_F+@*DL7X6S^A>LA1U" M6CC'9&\MX[;V9?6\R/T@\E9#N/D"P#@-0_=B_Y.SA$ERS?;)B9>0ODL)XQ#1 ML%W*+^(=^`&A')_PV)_$Q)T&=9HUH1&$$4:AR<.[J^5*;>O@,\QK"?YB>P4"G&H%**Z",))&SW+1'SQ"2]&K/ MT*-I"#'?'41338/V.FUP[YR@/7H(EI)K/03M9POI66E9''>VL"LM\7X7L,B5 M'Q3UZMM2-(K3>B-!BM=2O$$]AZV:FEK;#3A!4<0UBS.-J66J-KY6JK;6S\9[ M#7Q5PWPCE7"ECJ1?$E4#>V!R:%N(V0E!AQP0I"S)H.>-$KX?>^4:&M6T$.P) MGWCNC4<=5F:7'>,8*=+;?L!5>+M%411S#7J,QR(4TJ[6W?7HFY*7:@@3K_*- MM@L]2]5:S"#;9WK&0V_9SK;MF\-V<"_8WCSA\]PH11&]K+$>+113#7QR!:9' M0T-5!X\OPS![0V-TR`^2Y,>LLCA1ZR`=K4_>I]*(\Z9Y*:MU73GKR.P6$IQL M,!I:PJDO@)9U[Z8HZDW5J$,0QC*OE$VV38AKB8ZVQZ)6$TA])%RAD/5P&ZH^ M"&P4_BO``'GE$3(-"F5N9'-T7!E+U1R=654>7!E+T9O;G1$97-C7!E+T9O;G1$97-C2A4:6UE.L$*:KI4%W7OVV'>>X_5?#DP]0_# MB7\DHRZ[M3^K-V&E@V3^N/%J-O3;1=1==MTP&@7F%>8,05C\&)R$3$(NH9!0 M2HA%P\+'8"0(A87"0F&AL%!8*"P4%HH5BA6*%8H5BA6*%8H5BA6*%8H5BA.* M$XH3BA.*$XJ+E"_J@B)`S=3,+P9U6K>K-\?3=Q\.WL;UF&[O[J]TV)A!'8QKC14<-ZMM[]51WVT.Z\TN/=\.0:)FF[I5L^WU_:)O-L,NW?C^^<#\ M?!^_0_S&,<*4YM9WV]UM.'C0/:BCYIN:=OU=O587ZKA=MMW@,8#+&-X]99_: MI>^?JH^[];K[[I*DS^.!ONM[_>G*"`[@=8HIC^ED684_Y M7ZML\]^6YHS_7?$X[Q\"#`">//'4#0IE;F1S=')E86T-96YD;V)J#3(@,"!O M8FH\/"].=6US6S`@,R`P(%)=/CX-96YD;V)J#3,@,"!O8FH\/"]3+T0^/@UE M;F1O8FH--"`P(&]B:CP\+T-O=6YT(#$O5'EP92]086=EFMC.60B/SX*/'@Z>&UP;65T82!X M;6QN#IX;7!T:STB,RXQ+3&UL;G,Z<&1F>#TB:'1T M<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F>#I# M;VUP86YY/E-%0SPO<&1F>#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I3;W5R M8V5-;V1I9FEE9#Y$.C(P,#&UL;G,Z>&%P/2)H M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I# M&%P.D-R96%T;W)4;V]L/D%C&%P.DUE=&%D871A1&%T93X*("`@ M("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@ M&%P34TZ5F5RF4@-#D^/@T* -----END PRIVACY-ENHANCED MESSAGE-----